Evidence synthesis platform

Screen, extract, and pool in one review workspace

Multiple-reviewer screening, Cochrane-style meta-analysis, and PRISMA 2020 reporting in a single workflow - without moving data between tools.

No card required. Core workflow is free forever. Unlimited reviewers.

Systematic reviewsMeta-analysisPRISMA 2020Team screening
EvidenceFlow systematic review workspace on desktop and tablet

Teams

Blind review and arbitration

Statistics

IV, Mantel-Haenszel, and Peto pooling

PRISMA 2020

Flow diagrams from live screening counts

See EvidenceFlow in Action

One review, from screening to reporting

Real screens from a real review, in the order you’d actually use them.

Screening Interface

Two reviewers work this same queue independently - EvidenceFlow flags where they disagree before anyone moves on.

1. Screen · Screening

Screening Interface

Abstract viewer with AI relevance scores, include/exclude controls, conflict detection, and stage-by-stage progress.

  • ✓AI relevance scoring
  • ✓Three-stage screening queue
  • ✓Conflict detection & resolution
  • ✓Multi-reviewer support
Meta-analysis & Visualizations

Once extraction is done, EvidenceFlow pools your effect sizes and draws the forest plot from the same data - no copy-pasting into a separate stats tool.

2. Analyze · Analysis

Meta-analysis & Visualizations

Forest plots, funnel plots, PRISMA flow diagrams, and omics Manhattan plots - all generated from your extracted study data.

  • ✓Forest & funnel plots
  • ✓Fixed & random-effects pooling
  • ✓Omics variant aggregation
  • ✓One-click PDF export
PRISMA 2020 Flow Diagram

Your identification, screening, and inclusion counts feed this diagram directly - the numbers can't drift from what you actually screened.

3. Report · Reporting

PRISMA 2020 Flow Diagram

A publication-ready PRISMA 2020 flow diagram, drawn live from your real identification, screening, and inclusion counts.

  • ✓Auto-calculated from your counts
  • ✓Databases + other-methods layout
  • ✓Export PNG or PDF for your manuscript
Workflow

From question to publication, every step traceable

EvidenceFlow connects the entire evidence synthesis workflow in one place — from PICO to PRISMA, without hopping between tools.

Step 1 of 8

Question

Define your research question and PICO framework. Every decision downstream - screening, extraction, synthesis - traces back to this starting point.

  • ✓Population, intervention, comparator, outcome
  • ✓Inclusion and exclusion criteria live with the question
  • ✓Reviewers see the same frame at every later stage
Start a review

Research question

Do SGLT2 inhibitors reduce major adverse cardiovascular events versus usual care?

P
Population · Adults with type 2 diabetes
I
Intervention · SGLT2 inhibitor
C
Comparator · Placebo or usual care
O
Outcome · MACE at 12 months

Reproducible workflow

Every decision is traceable.

Built for review teams

Blind dual review, not a solo inbox.

Portable results

Export CSV, JSON, and PDF anytime.

Team

Built for reviewer teams, not just one person

Blind dual review, automatic disagreement detection, and a full audit trail — every decision accountable, every reviewer’s progress visible.

  • Blind dual review

    Two reviewers screen independently. Neither sees the other’s include or exclude until you open arbitration.

  • Conflict detection

    Disagreements are flagged automatically. Unresolved records stay pending — they never silently count as included.

  • Arbitration

    A third reviewer or the review manager records a final decision, with a rationale, on the conflicted study.

  • Audit trail

    Every decision keeps who, when, and which stage. Progress is visible to the team without breaking blindness.

Integrates with the sources and standards you already use

  • PubMedSource
  • CrossrefSource
  • OpenAlexSource
  • PRISMA 2020Standard
  • RISFormat
  • BibTeXFormat
  • CSVFormat
  • JSONFormat
Features

Everything you need for modern evidence synthesis

From import to publication-ready output in one platform - no stitching tools together.

📚

Literature Screening

Title, abstract, and full-text screening with blind dual review, conflict detection, and multi-reviewer collaboration.

📊

Meta-analysis Engine

Pool effect sizes and quantify heterogeneity in minutes, using fixed and random effects models with publication-ready forest and funnel plots.

🧬

Omics Data Integration

Synthesize evidence across populations and studies with GWAS variant aggregation, weighted gene-level RNA-seq summaries, and chromosome-level Manhattan plots.

🤖

AI-assisted Study Selection

Cut screening time by surfacing the most relevant studies first, with AI-powered relevance scoring against your research question.

📋

PRISMA Workflow

Stay reporting-compliant with zero manual bookkeeping, using automated PRISMA flow diagrams that track counts at every stage.

👥

Collaborative Reviews

Keep review teams in sync with role-based access, dual-reviewer screening, conflict detection, and a full audit trail.

Who It’s For

Built for every stage of evidence work

Whether you’re running a single review or coordinating a department, EvidenceFlow fits the workflow.

👨‍⚕️

Clinical Researchers

Conduct PRISMA-compliant systematic reviews without switching between screening, extraction, and reporting tools.

🧬

Bioinformaticians

Integrate GWAS, RNA-seq, and genomic datasets into your evidence synthesis alongside clinical literature.

🎓

Medical Students

Complete dissertations and evidence syntheses faster with AI-assisted screening and structured data extraction.

🏛️

Universities

Run collaborative evidence reviews across departments with role-based access and a shared audit trail.

EvidenceFlow

Built on principles

Methods are documented, analyses are reproducible, and your data stays portable - CSV, JSON, and PDF on every project.

🔬

Transparent

All statistical methods are documented and auditable. Reproducible analyses with full parameter history.

Read the docs
♻️

Reproducible

Export full data packages JSON, PDFs, and plots so every review step can be independently verified.

Methods guide
📦

Exportable

Your data is never locked in. Every project exports as CSV, JSON, and PDF, ready for reuse elsewhere.

See export options
🧩

Open Standards

Import from PubMed, RIS, and BibTeX, and generate PRISMA 2020-compliant flow diagrams out of the box.

PRISMA 2020 guide

FAQ

Frequently asked questions

What is EvidenceFlow?+

EvidenceFlow is an AI-assisted evidence synthesis platform for systematic reviews, meta-analysis, and omics research. It streamlines literature screening, structured data extraction, PRISMA 2020 reporting, and statistical analysis for researchers, clinicians, and bioinformaticians.

Is EvidenceFlow free to use?+

The core platform is free - literature import, manual screening, extraction, meta-analysis, and PRISMA reporting, with no subscription or seat limits. AI-assisted screening, extraction auto-fill, and manuscript drafting are a paid upgrade.

How does AI screening work in EvidenceFlow?+

EvidenceFlow uses AI to prioritize studies based on your research question, PICO framework, and inclusion/exclusion criteria. Each study receives a suggested decision, confidence score, and explanation, while final screening decisions always remain under researcher control.

What is the difference between EvidenceFlow and Rayyan or RevMan?+

EvidenceFlow combines collaborative literature screening, PRISMA workflow management, statistical analysis, and AI-assisted evidence synthesis within a single platform, reducing the need to switch between multiple research tools.

Can EvidenceFlow generate a PRISMA flow diagram?+

Yes. EvidenceFlow automatically tracks study counts throughout the review process and generates PRISMA 2020-compliant flow diagrams that can be exported with your reports.

What file formats can I import into EvidenceFlow?+

EvidenceFlow supports RIS, BibTeX, CSV, and direct PubMed search import, and you can upload full-text PDFs directly for full-text screening - making it easy to start new systematic review projects from existing reference libraries.

Is EvidenceFlow open source?+

No. EvidenceFlow is proprietary hosted software. The source repository is not public, and the platform is not licensed for copying or redistribution except under a separate written agreement — see the Software License page. Third-party open-source libraries remain under their own licenses. The core platform is free to use; AI-assisted features are a paid upgrade. Project data stays portable through CSV, JSON, and PDF exports.

Can I collaborate with multiple reviewers?+

Yes. EvidenceFlow supports multi-reviewer projects with role-based access, dual-reviewer screening, conflict detection, and an audit trail of every decision.

Which statistical models are supported?+

EvidenceFlow's meta-analysis engine supports both fixed-effect and random-effects (DerSimonian–Laird) pooling, with heterogeneity statistics including Cochran's Q, I², and Tau², visualized as forest and funnel plots.

Does EvidenceFlow support PRISMA 2020?+

Yes. PRISMA 2020 flow diagrams are generated automatically from your screening decisions and can be exported as part of your PDF or Word report.

Can I export my project?+

Yes. Export your review at any stage as PDF, Word, CSV, JSON, or PRISMA 2020 flow diagrams for sharing, publication, or further analysis.

Is my research data private?+

Yes. Your projects remain private to your workspace unless you explicitly invite collaborators to join them.

Who is EvidenceFlow designed for?+

EvidenceFlow is designed for researchers, clinicians, students, systematic review teams, and bioinformaticians conducting evidence synthesis across clinical and omics research.

Does EvidenceFlow support omics research?+

Yes. EvidenceFlow includes workflows for aggregating GWAS variants, gene expression (RNA-seq) results, and other omics data alongside traditional systematic reviews.

Get Started

From literature search to publication in one platform

Create a free account, import your references, and start screening with no configuration needed. AI-assisted screening, extraction, and manuscript drafting are available as a paid upgrade.